FDA Approves Lilly's Donanemab to Treat Early Symptomatic Alzheimer's Disease

Building Indiana

Jun 16, 2024

The Peripheral and Central Nervous System Drugs Advisory Committee by a unanimous vote confirmed the efficacy and safety of Eli Lilly and Company's (NYSE: LLY) donanemab for the tr…